Plasma erythropoietin level in patients with cirrhosis and its relationship to the severity of cirrhosis and renal function

Journal of Gastroenterology and Hepatology (Australia)

Volumn 18, Issue 10, 2003, Pages 1156-1161

  Yang, Ying Ying ^a,b   Lin, Han Chieh ^a,b   Lee, Wui Chiang ^a,b   Huang, Yi Tsau ^b   Hou, Ming Chih ^a,b   Lee, Fa Yauh ^a,b   Chang, Full Young ^a,b   Lee, Shou Dong ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Cirrhosis; Erythropoietin; Nitric oxide; Portal hypertension; Renal plasma flow

Indexed keywords

ERYTHROPOIETIN; NITRATE; NITRIC OXIDE; NITRITE;

ADULT; AGED; ANEMIA; ARTICLE; ASCITES; BLOOD LEVEL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEMODYNAMICS; HUMAN; KIDNEY FUNCTION; KIDNEY PLASMA FLOW; LIVER BLOOD FLOW; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PORTAL HYPERTENSION; PRIORITY JOURNAL; SYSTEMIC VASCULAR RESISTANCE; VASODILATATION; VENOUS PRESSURE;

EID: 0242487661     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2003.03144.x     Document Type: Article

References (45)

1. Erslev AJ. Erythropoietin. N. Engl. J. Med. 1991; 324: 1339-44.
2. Krantz SB. Erythropoietin. Blood 1991; 77: 419-34.
3. Nielsen OJ. Recombinant human erythropoietin: experimental and clinical applications. Scan. J. Clin. Lab. Invest. 1991; 51: 1-10.
4. Koury ST, Bounurant MC, Koury MJ. Localization of erythropoietin synthesizing cell in murine kidneys by in situ hybridization. Blood 1988; 71: 524-7.
5. Koury ST, Bounurant MC, Koury MJ. The site of erythropoietin production: localization of erythropoietin mRNA by radioactive in situ hybridization (response). Blood 1991; 78: 1470-1.
6. Koury ST, Bounurant MC, Koury MJ, Semeza GL. Localization of cells producing erythropoietin in murine liver by in situ hybridization. Blood 1991; 77: 2497-503.
7. Nielsen OJ, Egfjord M, Hirth P. The metabolism of recombinant erythropoietin in the isolated perfused rat liver. Liver 1990; 10: 343-9.
8. Spivak JL, Hogans BB. The in vivo metabolism of recombinant human erythropoietin in the rat. Blood 1989; 73: 90-9.
9. Jelkmann W. Erythropoietin; structure, control of production, and function. Physiol. Rev. 1992; 72: 449-89.
10. Fried WJ, Barone-Varelas J, Morley C. Factors that regulate extrarenal erythropoietin production. Blood Cells 1984; 10: 287-304.
11. Faquin WC, Schneider TJ, Goldberg MA. Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood 1992; 79: 1987-94.
12. Fried W, Gurney CW. Erythropoietin effect of plasma from mice receiving testosterone. Nature 1965; 206: 1160-1.
13. Fried W. Factors that affect the rate of erythropoietin production by extrarenal sites. Ann. NY Acad. Sci. 1989; 554: 1-8.
14. Spivak JL, Barnes DC, Fuchs E, Quinn TC. Serum immunoreactive erythropoietin in HIV-infected patients. JAMA 1989; 261: 3104-7.
15. Wrigley PFM, Malpas JS, Turnbull AL, Jenkins GC, McArt A. Secondary polycythemia due to uterine fibromyoma producing erythropoietin. Br. J. Haematol. 1971; 21: 551-5.
16. Da Silva JL, Lacombe C, Bruneval P et al. Tumor cells are the site of erythropoietin synthesis in human renal cancers associated with polycythemia. Blood 1990; 75: 577-82.
17. Siciliano M, Tomasello D, Milani A, Ricerca BM, Stori S, Rossi L. Reduced serum levels of immunoreactive erythropoietin in patients with cirrhosis and chronic anemia. Hepatology 1995; 22: 1132-5.
18. Pirisi M, Fabris C, Fallet E et al. Evidence for a multifactorial control of serum erythropoietin concentration in liver disease. Clin. Chim. Acta 1993; 219: 47-55.
19. Naughton BA, Liu P, Naughton GK, Gordon AS. Evidence for an EPO-stimulating factor in patients with renal and hepatic disease. Acta Haematol. 1983; 69: 171-9.
20. Jensen JD, Jensen LW, Madsen JK, Poulsen L. The metabolism of erythropoietin in liver cirrhosis patients compared with healthy volunteers. Eur. J. Haematol. 1995; 54: 111-16.
21. Klassen DK, Spivak JL. Hepatitis-related hepatic erythropoietin production. Am. J. Med. 1990; 89: 684-6.
22. Tacke F, Schoffski P, Ganser A, Manns M, Trautwein C. Erythropoietin plasma levels are elevated in chronic liver disease and correlate with anemia, liver dysfunction, bleeding episodes and interleukin-6 [Abstract]. Hepatology 2002; 36 (Suppl. 1): 216A.
23. Martin J, Moncada S. Blood pressure, erythropoietin, and nitric oxide [Letter]. Lancet 1988; 1: 644.
24. Morales-Ruiz M, Jiménez W, Perez-Sala D et al. Increased nitric oxide synthase expression in arterial vessels of cirrhotic rats with ascites. Hepatology 1996; 24: 1481-6.
25. Martin PY, Gines P, Schrier RW. Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis. N. Engl. J. Med. 1998; 339: 533-41.
26. Pugh RNH, Murray-Lyon M, Dawson JL, Pietroni MC, Williams R. Transection of oesophagus for bleeding oesophageal varices. Br. J. Surg. 1973; 60: 646-9.
27. Lee WC, Lin HC, Hou MC et al. Effect of anemia on hemodynamics in patients with cirrhosis. J. Gastroenterol. Hepatol. 1999; 14: 370-5.
28. Cirera I, Elizalde JI, Piqué JM et al. Anaemia worsens hyperdynamic circulation of patients with cirrhosis and portal hypertension. Dig. Dis. Sci. 1997; 42: 1697-702.
29. Denié C, Poynard T, Gadano A et al. Influence of anaemia on haemodynamic changes in patients with cirrhosis. Gastroenterol. Clin. Biol. 1997; 21: 29-33.
30. Lin HC, Tai YT, Lee FY et al. Hemodynamic evaluation of octreotide in patients with hepatitis B-related cirrhosis. Gastroenterology 1992; 103: 229-34.
31. 131I-orthoiodohippurate. Mayo Clin. Proc. 1971; 46: 524-31.
32. Hsia HC, Lin HC, Tsai YT et al. The effects of chronic administration of indomethacin and misoprostol on renal function in cirrhotic patients with or without ascites. Scand. J. Gastroenterol. 1995; 30: 194-9.
33. Garcia JF, Sherwood J, Goldwasser E. Radioimmunoassay of erythropoietin. Blood Cells 1979; 5: 401-19.
34. Porter DL, Goldberg HA. Physiology of erythropoietin production. Semin. Hematol. 1994; 31: 112-21.
35. Bondurant MC, Koury MJ. Anemia induces accumulation of erythropoietin mRNA in the kidney and liver. Mol. Cell Biol. 1986; 6: 2731-3.
36. Schooley JC, Mahlann LJ. Erythropoietin production in the anephric rat. I. Relationship between nephrectomy, time of the hypoxia exposure, and erythropoietin production. Blood 1972; 39: 31-8.
37. Sherlock S, Dooley J, eds. Hepatic cirrhosis. In: Diseases of the Liver and Biliary System. Australia: Blackwell Science, 1997; 378-81.
38. Meng HC, Lin HC, Tsai YT et al. Relationship between the severity of cirrhosis and haemodynamic values in patients with cirrhosis. J. Gastroenterol. Hepatol. 1994; 9: 148-53.
39. Lee FY, Lu RH, Tsai YT et al. Plasma interleukin-6 levels in patients with cirrhosis: relationship to endotoxemia, tumor necrosis factor-α, and hyperdynamic circulation. Scand. J. Gastroenterol. 1996; 31: 500-5.
40. Epstein M, Levinson R, Sancho J, Haber E, Re R. Characterization of renin-aldosterone system in decompensated cirrhosis. Circ. Res. 1977; 41: 818-29.
41. Bosch J, Arroyo V, Betriu A et al. Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis. Gastroenterology 1980; 78: 92-9.
42. Dworkin LD, Sun AM, Brenner BM. The renal circulations: Total renal blood flow: Methods of measurement. In: Brennere BM, ed. The Kidney, 6th edn. Philadelphia: WB Saunders, 2000; 291-4.
43. Kew MC, Brunt PW, Varma RR, Hourigan KJ, Williams HS, Sherlock S. Renal and intrarenal blood flow in cirrhosis of the liver. Lancet 1971; 2: 504-10.
44. Sacerdoti D, Bolognesi M, Merkel C, Angeli P, Gatta A. Renal vasoconstriction in cirrhosis evaluated by duplex Doppler ultrasonography. Hepatology 1993; 17: 219-24.
45. Noguchi K, Yamashiro S, Matsuzaki T et al. Effect of 1-week treatment with erythropoietin on the vascular endothelial function in anaesthetized rabbits. Br. J. Pharmacol. 2001; 133: 395-405.